Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000256370) titled 'Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum and vivax malaria in Eritrea in 2024' on March 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Ministry of Health
Condition:
Malaria
Malaria
Infection - Studies of infection and infectious agents
Intervention:
The study aims to evaluate efficacy and safety of artemether-lumefantrine in the treatment of treatment of uncomplicated Plasmodium falcip...